Do low total stool SCFAs and low stool propionate indicate reduced microbial fermentation?

Age-related shifts in the gut microbiome and colonic transit time highlight the clinical relevance of monitoring short-chain fatty acids (SCFAs) to assess mucosal and immunological health.

Clinical implications of fecal SCFA levels

• Low total stool SCFAs and low stool propionate are validated, practical indicators of reduced colonic microbial fermentation. These low levels typically reflect diminished dietary substrate (such as fiber) or reduced metabolic activity of key saccharolytic taxa like Bacteroides and Ruminococcus.
• Because the host epithelium rapidly absorbs approximately 95% of colonic SCFAs, fecal concentrations represent the residual, unabsorbed fraction. Consequently, interpretation must consider individual transit times and absorption kinetics.

Mechanistic pathways of SCFAs

• Epithelial metabolism: Butyrate acts as the primary energy source for colonocytes, undergoing mitochondrial beta-oxidation and entering the TCA cycle to sustain cellular proliferation and mucosal health.
• Immune regulation: SCFAs serve as natural ligands for GPCRs (GPR43, GPR41, and GPR109A) and function as histone deacetylase (HDAC) inhibitors. These mechanisms drive regulatory T cell (Treg) differentiation and boost anti-inflammatory cytokines like IL-10 and IL-22 to regulate local immune tone.
• Barrier defense: By inhibiting HDACs and activating GPCRs, SCFAs upregulate critical tight junction proteins—including ZO-1, occludin, and claudins—which increases transepithelial electrical resistance (TEER) and prevents paracellular barrier breakdown.

Bottom line

• Low total fecal SCFAs and propionate signal a decline in microbial fermentation, directly impacting the molecular pathways that fuel colonocytes, maintain immunological tolerance, and protect intestinal barrier integrity.